Q3 2025 Holdings
Filed 2025-11-14 | 82 holdings | $162.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunothera(MLTX) | CLASS A ORD | 61559X104 | $6.9K | 956 | 0.0% |
| Axsome Therapeutics(AXSM) | COM | 05464T104 | $123.9K | 1,020 | 0.1% |
| Moderna Inc(MRNA) | COM | 60770K107 | $144.6K | 5,600 | 0.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $151.5K | 4,205 | 0.1% |
| Incyte Corporation(INCY) | COM | 45337C102 | $257.0K | 3,030 | 0.2% |
| Illumina Inc(ILMN) | COM | 452327109 | $259.0K | 2,727 | 0.2% |
| Jazz Pharma PLC(JAZZ) | SHS USD | G50871105 | $295.8K | 2,244 | 0.2% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $303.5K | 3,760 | 0.2% |
| United Therapeutics(UTHR) | COM | 91307C102 | $320.7K | 765 | 0.2% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $327.4K | 9,280 | 0.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $332.7K | 2,375 | 0.2% |
| Madrigal Pharma(MDGL) | COM | 558868105 | $334.8K | 730 | 0.2% |
| Neurocrine Biosciences(NBIX) | COM | 64125C109 | $415.5K | 2,960 | 0.3% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $426.7K | 12,590 | 0.3% |
| Bristol Myers Squibb(BMY) | COM | 110122108 | $487.1K | 10,800 | 0.3% |
| The Cigna Group(CI) | COM | 125523100 | $518.9K | 1,800 | 0.3% |
| PTC Therapeutics(PTCT) | COM | 69366J200 | $523.8K | 8,535 | 0.3% |
| Hinge Health Inc(HNGE) | CL A | 433313103 | $550.0K | 11,206 | 0.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $561.9K | 10,223 | 0.3% |
| Ionis Pharmaceutical(IONS) | COM | 462222100 | $602.2K | 9,205 | 0.4% |
| Omada Health Inc(OMDA) | COM | 68170A108 | $608.0K | 27,500 | 0.4% |
| Bridgebio Pharma(BBIO) | COM | 10806X102 | $709.0K | 13,650 | 0.4% |
| Ascendis Pharma(ASND) | SP ADR | 04351P101 | $715.9K | 3,601 | 0.4% |
| Arrivent Biopharma(AVBP) | COM | 04272N102 | $723.9K | 39,235 | 0.4% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $756.6K | 50,007 | 0.5% |
| Radnet Inc(RDNT) | COM | 750491102 | $762.1K | 10,000 | 0.5% |
| ARS Pharmaceuticals(SPRY) | COM | 82835W108 | $821.9K | 81,785 | 0.5% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $834.6K | 678,574 | 0.5% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $877.3K | 30,188 | 0.5% |
| Privia Health Group(PRVA) | COM | 74276R102 | $908.9K | 36,500 | 0.6% |
| Amicus Therapeutics(FOLD) | COM | 03152W109 | $938.5K | 119,105 | 0.6% |
| Alignment Healthcare(ALHC) | COM | 01625V104 | $951.0K | 54,500 | 0.6% |
| Trevi Therapeutics(TRVI) | COM | 89532M101 | $969.4K | 105,950 | 0.6% |
| Merus B V | COM | N5749R100 | $1.1M | 11,545 | 0.7% |
| Tarsus Pharmaceutical(TARS) | COM | 87650L103 | $1.1M | 18,405 | 0.7% |
| Edwards Lifescience(EW) | COM | 28176E108 | $1.2M | 15,000 | 0.7% |
| Syndax Pharmaceuticals(SNDX) | COM | 87164F105 | $1.2M | 79,430 | 0.8% |
| Mineralys Therapeutics(MLYS) | COM | 603170101 | $1.3M | 33,885 | 0.8% |
| Rapport Therapeutics(RAPP) | COM | 75383L102 | $1.3M | 43,480 | 0.8% |
| Biomarin Pharmac Inc(BMRN) | COM | 09061G101 | $1.4M | 25,030 | 0.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $1.4M | 16,400 | 0.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $1.4M | 20,700 | 0.9% |
| Astrazeneca(AZN) | SP ADR | 046353108 | $1.4M | 18,750 | 0.9% |
| Alnylam Pharmacuetcl(ALNY) | COM | 02043Q107 | $1.5M | 3,273 | 0.9% |
| Summit Therapeutics(SMMT) | COM | 86627T108 | $1.5M | 74,070 | 0.9% |
| Stryker Corp(SYK) | COM | 863667101 | $1.6M | 4,300 | 1.0% |
| Biontech SE(BNTX) | SP ADR | 09075V102 | $1.7M | 17,660 | 1.1% |
| Uniqure N.V.(QURE) | SHS | N90064101 | $1.8M | 30,740 | 1.1% |
| Thermo Fisher Scientific(TMO) | COM | 883556102 | $1.9M | 3,900 | 1.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.9M | 13,425 | 1.2% |